Allergy Immunotherapies Market Geographical Analysis by 2031 Over the years, the allergy immunotherapies market has grown significantly owing to rising allergic conditions such as asthma, allergic rhinitis, and food allergies. A promising long-term relief has emerged with immunotherapy, especially by employing techniques such as SCIT and SLIT. The market was projected at US$ 2.16 Bn in 2021 and US$ xx Bn in 2023. It is expected to reach US$ 5.11 Bn by 2031 and record a CAGR of 9.0% till 2031. https://www.theinsightpartners.com/assets/rd-new-images/by_geography/allergy-immunotherapies-market-global-geography.webp Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, South & Central America Conclusion Allergy Immunotherapies Market will continue to grow in technology advancement and also an increase in the patient pool. This is supposed to change further, with increasing awareness and availability of options, offering hope for many sufferers.